In addition, Pearson’s correlation analyses among clinical glioma specimens showed significant positive correlations between HOXB5 and SRSF1 expression in each WHO grade glioma and among the total glioma samples (Fig. 7g). Here, HOXB5 is linked to central nervous system cancer.